• Home
• FAQs
• FOIA
• Careers
• Contact
• HEAT
• Download Reader
• Twitter
• YouTube

• Switch to the full site
• Report Fraud
• Home
• What's New
• Enforcement Actions
• Most Wanted Fugitives
• Spotlight Articles
• Newsroom

• Home
• Reports & Publications
• Office of Audit Services
• Center For Medicare and Medicaid Services
• Report

Audit (A-05-11-00027)

10-07-2011
Review of Medicare Payments for NovoSeven Coagulation Factor VIIA to Indiana Hemophilia and Thrombosis Center, Inc. From January 1, 2008, Through December 31, 2009

Executive Summary

The Indiana Hemophilia and Thrombosis Center, Inc. (the Center) received net Medicare overpayments for NovoSeven dispensations of $435,000 for the period January 1, 2008, through December 31, 2009.

Complete Report

Download the complete report

Adobe® Acrobat® is required to read PDF files.

Copies can also be obtained by contacting the Office of Public Affairs at 202-619-1343.

Let's start by choosing a topic

• Compendium

  Priority recommendations summarized.

• FY 2014 Work Plan

  OIG projects planned for 2014.

• Semiannual Report

  Significant OIG activities in 6-month increments.

• Compliance 101

  Free educational resources.

• Advisory Opinions

  Legal opinions issued by the OIG about the application of its fraud and abuse authorities.

• Child Support Enforcement

  OIG plays a role in pursuing deadbeat parents.

• All Reports and Publications
  • Office of Audit Services
    • Administration on Aging (AoA)
    • Administration for Children and Families (ACF)
    • Centers for Disease Control and Prevention (CDC)
    • Centers for Medicare and Medicaid Services (CMS)
    • Food and Drug Administration (FDA)
    • General Departmental
    • Health Resources and Services
      Administration (HRSA)
    • Indian Health Service (IHS)
    • National Institutes of Health (NIH)
    • Federal/State Joint Audit Initiatives
    • Substance Abuse and Mental Health Services Administration (SAMHSA)
  • Office of Evaluation and Inspections
  • Health Care Fraud and Abuse Control Program Report
  • Semiannual Reports to Congress
  • Medicaid Integrity Reports
  • Top Management & Performance Challenges
  • Compendium of Priority Recommendations
  • Strategic Plan
  • Work Plan
  • Portfolio and Other Reports
  • Freedom of Information Act (FOIA)
  • Federal Register Notices
  • Regulatory Authorities
  • OIG Budget
  • Recovery Act Oversight Reports
  • Recovery Act-related Audit and Inspection Reports
• Archives
  • Office of Audit Services
    • Administration for Children and Families (ACF)
    • Centers for Disease Control and Prevention (CDC)
    • Centers for Medicare and Medicaid Services (CMS)
    • Food and Drug Administration (FDA)
    • General Departmental
    • Health Resources and Services
      Administration (HRSA)
    • Indian Health Service (IHS)
    • National Institutes of Health (NIH)
    • Federal/State Joint Audit Initiatives
    • Substance Abuse and Mental Health Services Administration (SAMHSA)
  • Office of Evaluation and Inspections
  • Health Care Fraud and Abuse Control Program Report
  • Semiannual Reports to Congress
  • Medicaid Integrity Reports
  • Top Management & Performance Challenges
  • Compendium of Unimplemented Recommendations: Orange Book
  • Compendium of Unimplemented Recommendations: Red Book
  • Work Plan
  • Federal Register Notices
  • Regulatory Authorities
  • OIG Budget
  • Testimony & Speeches
  • Safe Harbor Regulations
  • Enforcement Action: False and Fraudulent Claims
  • Enforcement Action: Kickback and Physician Self-Referral
  • Enforcement Action: Patient Dumping
  • Enforcement Action: Select Agents and Toxins

Get Email Updates

Stay up to date on the latest OIG news and opinions